Intriguingly, each PDX model additionally revealed unique dropout genes, such as CD79A in ALL-199 or TFRC in ALL-265 (Figs. 2C and S6), suggesting a capacity of the screening approach to detect patient sample-specific dependencies. The gene discussed is CD79A; the disease is acute lymphoblastic leukemia.